Thrivent Financial for Lutherans Reduces Holdings in Alkermes plc (NASDAQ:ALKS)
Thrivent Financial for Lutherans reduced its position in Alkermes plc (NASDAQ:ALKS – Free Report) by 3.3% in the fourth ...
Alkermes spinoff Mural plunges on plans to halt ovarian cancer trial
Mural Oncology (NASDAQ:MURA) stock plummets 47% as the company, a spinoff of Alkermes (ALKS) halts a Phase 3 trial for its ...
pharmaphorum2d
6th GxP Cloud Compliance Summit 2025
The 6th GxP Cloud Compliance Summit is uniting Life Science companies to manage data security risks, validate internal and ...
Analysts Set Alkermes plc (NASDAQ:ALKS) Target Price at $38.46
Alkermes plc (NASDAQ:ALKS – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen research firms that are covering the stock, MarketBeat.com reports. Four investment ...
CWEB4d
Comparative Analysis of Pharmaceutical Companies: OptiNose, Collegium Pharmaceutical, Alkermes, and Deciphera Pharmaceuticals
OptiNose, Inc. (NASDAQ:OPTN) faces a pessimistic outlook from investment analysts with a target price significantly lower than its market price. Collegium Pharmaceutical, Inc. (COLL) is perceived as ...
Zealand Pharma upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Laura Hindley upgraded Zealand Pharma (ZLDPF) to Overweight from Equal Weight with a DKK 750 price target The ...